MELOE‐1 stimulates a broad pre‐existing T‐cell repertoire in melanoma patients against a HLA‐A*0201‐restricted epitope of MELOE‐1 [10] and is involved in immunosurveillance of melanoma [11]. The gene discussed is HLA-A; the disease is melanoma.